DNMT3A and gastric cancer: Additionally, we found a significantly higher expression of DNMT3a in the chemotherapy‐resistant (Non‐response) group compared to the chemotherapy‐sensitive group (Response) in the GSE62254 cohort of gastric cancer patients (Figure S3I).